READY TO USE LEICA BIOSYSTEMS IMMUNOHISTOCHEMICAL MARKERS: PANEL PARA DERMATOPATOLOGÍA - COFEPRIS Registration 856R2019 SSA
Access comprehensive regulatory information for READY TO USE LEICA BIOSYSTEMS IMMUNOHISTOCHEMICAL MARKERS: PANEL PARA DERMATOPATOLOGÍA (READY TO USE LEICA BIOSYSTEMS IMMUNOHISTOCHEMICAL MARKERS: PANEL PARA DERMATOPATOLOGÍA) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 856R2019 SSA and manufactured by BECKMAN COULTER DE MÉXICO, S.A. DE C.V.. The device was registered on April 24, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
MARCADORES PARA LA IDENTIFICACIÓN CUALITATIVA DE PROTEÍNAS FIJADOS EN FORMALINA E INCLUIDOS EN PARAFINA MEDIANTE TINCIÓN INMUNOHISTOQUÍMICA. LA INTERPRETACIÓN CLÍNICA DE CUALQUIER TINCIÓN O DE LA AUSENCIA DE ÉSTA DEBE COMPLETARSE CON ESTUDIOS MORFOLÓGICOS
MARKERS FOR THE QUALITATIVE IDENTIFICATION OF FORMALIN-BOUND PROTEINS INCLUDED IN PARAFFIN BY IMMUNOHISTOCHEMICAL STAINING. CLINICAL INTERPRETATION OF ANY STAINING OR ABSENCE OF STAINING SHOULD BE SUPPLEMENTED BY MORPHOLOGICAL STUDIES